NSE filing, NSE: ESTER. Summary written from the filing by ALFA Finder's alert engine.
Ester Industries Ltd: key numbers
- Share price
- ₹88.41
- Market cap
- ₹922.1 Cr
- Revenue (annual)
- ₹1,375 Cr
- Net profit (annual)
- ₹-27.47 Cr
- P/E (TTM)
- 42.1×Sector 45.0×
- Promoter holding
- 62.31%-0.01% QoQ
- FII holding
- 0.12%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Ester Industries Ltd
All →Ester Industries Investor Presentation: Key Takeaways
Q2 FY27 consolidated income ₹449 Cr (+25.7%), EBITDA ₹45.1 Cr (+160%), margin 10.0%, PAT ₹7.8 Cr vs prior loss. Film-led recovery; Specialty volumes down.
Ester Industries Other Announcement
Ester Industries filed its quarterly Monitoring Agency report for the convertible-warrants preferential issue. CRISIL confirmed the issue proceeds were utilised as per the offer document with no deviation.
Ester Industries Q2 FY27 Results: Turns Profitable, Net Profit ₹7.8 Cr
Ester Industries Ltd reported revenue from operations of ₹443.8 Cr (+25.3% YoY) and net profit of ₹7.8 Cr for Q2 FY27.
- Key figure
- Net profit ₹7.8 Cr
Ester Industries Board Meeting Date
Ester Industries informs that its Board will meet on 3 Nov 2026 to approve un-audited Q2/H1 results. No financial figures or other decisions are announced at this stage.
Ester Industries Other Announcement
Ester Industries Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026, as per SEBI regulations.
Ester Industries Promoter Selling: ₹3.35 Cr
Modi Rubber Limited, part of the promoter group of Ester Industries Ltd, sold 3,30,112 shares. The open market transaction was valued at approximately ₹3.35 Crore.
- Value
- ₹3.35 Cr
Other results update announcements
All →Steel Exchange India Results Update
Steel Exchange India Ltd reported a nine-fold surge in Q2 FY27 PAT to ₹18 Crore. Revenue rose 46% to ₹343 Crore alongside a ₹102 Crore debt reduction.
- quarterly production
- 69617.42 MT
Alembic Pharmaceuticals Results Update
Alembic Pharmaceuticals reported Q2 FY27 revenue growth of 36% to ₹2,603 Crore. Net profit surged 81% to ₹335 Crore, driven by exceptional US business performance.
- Value
- ₹2,603 Cr
SJS Enterprises Results Update
S.J.S. Enterprises reported record quarterly revenue of Rs. 282.73 Crore, up 16.9% YoY. Net profit for Q2FY27 rose 34.8% YoY to Rs. 58.33 Crore.
- Value
- ₹282.7 Cr
Meghmani Organics Results Update
MOL reported Q2 FY27 revenue of ₹658.2 crore, up 18% YoY, with net profit of ₹45.3 crore. EBITDA margin eased to 10.8% on elevated input costs.
GPT Infraprojects Results Update
GPT Infraprojects reported Q2 FY27 revenue of ₹291.4 crore and PAT of ₹18.3 crore. Order inflow was ₹1,491 crore; interim dividend of ₹1 declared.
- Order book
- ₹5,373 Cr
Indo Count Industries Results Update
Indo Count reported record Q2 FY27 income of ₹1,699 Cr and PAT of ₹132 Cr. H1 EBITDA grew 73% YoY to ₹420 Cr.